M. Tesson-werner, Transferts embryonnaires en FIV et ICSI : facteurs pronostiques

. Agence-de-biomédecine, Evaluation des résultats des centres d'assistance médicale à la procréation pratiquant la fécondation in vitro en France, 2011.

. Agence-de-biomédecine, Evaluation des résultats des centres d'assistance médicale à la procréation pratiquant la fécondation in vitro en France, 2012.

A. Society-for-reproductive and . Medicine, Ageing and infertility in women : a committee opinion, Ferti1 Steri1, vol.78, issue.1, pp.215-219, 2002.

T. Timeva, T. Milachich, L. Petkova, D. Barov, and A. Shterev, Assesment of the woman's age as a main predictive factor of assisted reproductive technology treatment outcome, pp.22-29, 2006.

T. Tan, M. Lau, S. Loh, and H. Tan, Female ageing and reproductive outcome in assisted reproduction cycles, Singapore Medical Journal, vol.55, issue.6, pp.305-309, 2014.
DOI : 10.11622/smedj.2014081

A. Lintsen, M. Eijkemans, C. Hunault, C. Bouwmans, L. Hakkaart et al., Predicting ongoing pregnancy chances afler lVF and lCSl : a national prospective study

C. Augood, K. Duckitt, and A. Templeton, Smoking and female infertility: a systematic review and meta-analysis, Human Reproduction, vol.13, issue.6, pp.1532-1539, 1998.
DOI : 10.1093/humrep/13.6.1532

A. Fuentes, A. Munoz, K. Barnhart, B. Arguello, M. Diaz et al., Recent cigarette smoking and assisted reproductive technologies outcome, Fertility and Sterility, vol.93, issue.1, pp.89-95, 2010.
DOI : 10.1016/j.fertnstert.2008.09.073

E. Sloter, T. Schmid, F. Marchetti, B. Eskenazi, J. Nath et al., Quantitative effects of male age on sperm motion, Human Reproduction, vol.21, issue.11, pp.2868-2875, 2006.
DOI : 10.1093/humrep/del250

X. Chen, W. Zhang, Y. Luo, X. Long, and X. Sun, fertilisation pregnancy outcome, Andrologia, vol.39, issue.2, pp.111-117, 2009.
DOI : 10.1111/j.1439-0272.2008.00898.x

J. Antoine, O. Fiori, and J. Mandelbaum, Peut-on pr??voir la qualit?? ovocytaire par la qualit?? de la r??ponse?, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.35, issue.5, pp.2-47, 2006.
DOI : 10.1016/S0368-2315(06)76442-0

P. Bacrie, Low circulating anti-Müllerian hormone and normal follicle stimulating hormone levels : which prognosis in an IVF program?, Gyobfe, vol.40, pp.7-8411, 2012.

R. Fanchin, L. Schonäuer, C. Righini, N. Frydman, R. Frydman et al., Serum anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation, Human Reproduction, vol.18, issue.2, pp.328-361, 2003.
DOI : 10.1093/humrep/deg043

URL : http://humrep.oxfordjournals.org/cgi/content/short/18/2/328

D. Seifer, M. Laughlin, D. Christian, and B. , Early follicular serum m??llerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles, Fertility and Sterility, vol.77, issue.3, pp.468-515, 2002.
DOI : 10.1016/S0015-0282(01)03201-0

F. Broekmans, J. Kwee, D. Hendriks, B. Mol, and C. Lambalk, A systematic review of tests predicting ovarian reserve and IVF outcome, Human Reproduction Update, vol.12, issue.6, pp.685-718, 2006.
DOI : 10.1093/humupd/dml034

L. Joine, R. Robinson, W. Bates, and A. Propst, Establishing institutional Critical Values of

M. Kehila, S. Kebaili, I. Bougmiza, S. Meddeb, S. Boughizane et al., Influence de l'épaisseur de l'endomètre sur l'implantation embryonnaire en fécondation in vitro. A propos de 414 cas, LA TUNISIE MEDICALE, vol.88, issue.12, pp.928-932, 2010.

E. Kolibianakis, J. Collins, B. Tarlatzis, P. Devroey, K. Diedrich et al., Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis, Human Reproduction Update, vol.12, issue.6, pp.651-671, 2006.
DOI : 10.1093/humupd/dml038

K. Lata, N. Malhotra, M. Naha, N. Singh, A. Tiwari et al., Comparison of gonadotropin-releasing hormone agonist with GnRH antagonist in polycystic ovary syndrome patients undergoing in vitro fertilization cycle : Retrospective analysis from a tertiary center and review of literature, Journal of Human Reproductive Sciences, vol.7, issue.1, pp.52-57, 2014.

J. Xiao, C. Su, and X. Zeng, Comparisons of GnRH Antagonist versus GnRH Agonist Protocol in Supposed Normal Ovarian Responders Undergoing IVF: A Systematic Review and Meta-Analysis, PLoS ONE, vol.27, issue.9, 2014.
DOI : 10.1371/journal.pone.0106854.s002

G. Griesinger, K. Diedrich, B. Tarlatzis, and E. Kolibianis, GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis, Reproductive BioMedicine Online, vol.13, issue.5, pp.628-638, 2006.
DOI : 10.1016/S1472-6483(10)60652-9

J. Pundir, S. Sunkara, T. El-toukhy, and Y. Khalaf, Meta-analysis of GnRH antagonist protocols: do they reduce the risk of OHSS in PCOS?, Reproductive BioMedicine Online, vol.24, issue.1, pp.6-22, 2012.
DOI : 10.1016/j.rbmo.2011.09.017

W. Hehenkamp, C. Looman, A. Themmen, D. Jong, F. Velde et al., Anti-M??llerian Hormone Levels in the Spontaneous Menstrual Cycle Do Not Show Substantial Fluctuation, The Journal of Clinical Endocrinology & Metabolism, vol.91, issue.10, pp.4057-4063, 2006.
DOI : 10.1210/jc.2006-0331

L. Marca, A. Stabile, G. , A. Carducci, A. Volpe et al., Serum anti-Mullerian hormone throughout the human menstrual cycle, Human Reproduction, vol.21, issue.12, pp.3103-3107, 2006.
DOI : 10.1093/humrep/del291

S. Tsepelidis, F. Devreker, I. Demeestere, A. Flahaut, C. Gervy et al., Stable serum levels of anti-Mullerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women, Human Reproduction, vol.22, issue.7, pp.1837-1877, 2007.
DOI : 10.1093/humrep/dem101